136 related articles for article (PubMed ID: 30483733)
1. Hyaluronic acid-chitosan nanoparticles encoding CrmA attenuate interleukin-1β induced inflammation in synoviocytes in vitro.
Qiu B; Xu XF; Deng RH; Xia GQ; Shang XF; Zhou PH
Int J Mol Med; 2019 Feb; 43(2):1076-1084. PubMed ID: 30483733
[TBL] [Abstract][Full Text] [Related]
2. Chitosan/hyaluronic acid/plasmid-DNA nanoparticles encoding interleukin-1 receptor antagonist attenuate inflammation in synoviocytes induced by interleukin-1 beta.
Deng RH; Qiu B; Zhou PH
J Mater Sci Mater Med; 2018 Oct; 29(10):155. PubMed ID: 30276528
[TBL] [Abstract][Full Text] [Related]
3. Chondroprotective Effects of Hyaluronic Acid-Chitosan Nanoparticles Containing Plasmid DNA Encoding Cytokine Response Modifier A in a Rat Knee Osteoarthritis Model.
Zhou PH; Qiu B; Deng RH; Li HJ; Xu XF; Shang XF
Cell Physiol Biochem; 2018; 47(3):1207-1216. PubMed ID: 29913441
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of interleukin-1beta-stimulated dedifferentiation of chondrocytes via controlled release of CrmA from hyaluronic acid-chitosan microspheres.
Ma BL; Zhou PH; Xie T; Shi L; Qiu B; Wang Q
BMC Musculoskelet Disord; 2015 Mar; 16():61. PubMed ID: 25888442
[TBL] [Abstract][Full Text] [Related]
5. Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis.
Lu HD; Zhao HQ; Wang K; Lv LL
Int J Pharm; 2011 Nov; 420(2):358-65. PubMed ID: 21911044
[TBL] [Abstract][Full Text] [Related]
6. Controlled Release of Interleukin-1 Receptor Antagonist from Hyaluronic Acid-Chitosan Microspheres Attenuates Interleukin-1
Qiu B; Gong M; He QT; Zhou PH
Biomed Res Int; 2016; 2016():6290957. PubMed ID: 27872853
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of hyaluronic acid/chitosan nanoparticles for the delivery of curcuminoid in knee osteoarthritis and an in vitro evaluation in chondrocytes.
Wang J; Wang X; Cao Y; Huang T; Song DX; Tao HR
Int J Mol Med; 2018 Nov; 42(5):2604-2614. PubMed ID: 30106112
[TBL] [Abstract][Full Text] [Related]
8. High-Molecular-Weight Hyaluronic Acid Inhibits IL-1β-Induced Synovial Inflammation and Macrophage Polarization through the GRP78-NF-κB Signaling Pathway.
Lee CH; Chiang CF; Kuo FC; Su SC; Huang CL; Liu JS; Lu CH; Hsieh CH; Wang CC; Lee CH; Shen PH
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769349
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic Acid Modified Curcumin-Loaded Chitosan Nanoparticles Inhibit Chondrocyte Apoptosis to Attenuate Osteoarthritis via Upregulation of Activator Protein 1 and RUNX Family Transcription Factor 2.
Wang J; Zhang L; Zhu J; Gu J; Wang X; Tao H
J Biomed Nanotechnol; 2022 Jan; 18(1):144-157. PubMed ID: 35180907
[TBL] [Abstract][Full Text] [Related]
10. The autocrine role of proteoglycan-4 (PRG4) in modulating osteoarthritic synoviocyte proliferation and expression of matrix degrading enzymes.
Alquraini A; Jamal M; Zhang L; Schmidt T; Jay GD; Elsaid KA
Arthritis Res Ther; 2017 May; 19(1):89. PubMed ID: 28482921
[TBL] [Abstract][Full Text] [Related]
11. Chitosan-graft-polyethylenimine/DNA nanoparticles as novel non-viral gene delivery vectors targeting osteoarthritis.
Lu H; Dai Y; Lv L; Zhao H
PLoS One; 2014; 9(1):e84703. PubMed ID: 24392152
[TBL] [Abstract][Full Text] [Related]
12. Anti-Inflammatory Performance of Lactose-Modified Chitosan and Hyaluronic Acid Mixtures in an In Vitro Macrophage-Mediated Inflammation Osteoarthritis Model.
Tarricone E; Mattiuzzo E; Belluzzi E; Elia R; Benetti A; Venerando R; Vindigni V; Ruggieri P; Brun P
Cells; 2020 May; 9(6):. PubMed ID: 32466461
[TBL] [Abstract][Full Text] [Related]
13. Novel Hybrid Gels Made of High and Low Molecular Weight Hyaluronic Acid Induce Proliferation and Reduce Inflammation in an Osteoarthritis
Stellavato A; Vassallo V; La Gatta A; Pirozzi AVA; De Rosa M; Balato G; D'Addona A; Tirino V; Ruosi C; Schiraldi C
Biomed Res Int; 2019; 2019():4328219. PubMed ID: 31179322
[TBL] [Abstract][Full Text] [Related]
14. Porous chitosan scaffolds with embedded hyaluronic acid/chitosan/plasmid-DNA nanoparticles encoding TGF-β1 induce DNA controlled release, transfected chondrocytes, and promoted cell proliferation.
Lu H; Lv L; Dai Y; Wu G; Zhao H; Zhang F
PLoS One; 2013; 8(7):e69950. PubMed ID: 23894564
[TBL] [Abstract][Full Text] [Related]
15. l-Glutathione enhances antioxidant capacity of hyaluronic acid and modulates expression of pro-inflammatory cytokines in human fibroblast-like synoviocytes.
Yang KC; Wu CC; Chen WY; Sumi S; Huang TL
J Biomed Mater Res A; 2016 Aug; 104(8):2071-9. PubMed ID: 27027581
[TBL] [Abstract][Full Text] [Related]
16. Nanotherapy in Joints: Increasing Endogenous Hyaluronan Production by Delivering Hyaluronan Synthase 2.
Li H; Guo H; Lei C; Liu L; Xu L; Feng Y; Ke J; Fang W; Song H; Xu C; Yu C; Long X
Adv Mater; 2019 Nov; 31(46):e1904535. PubMed ID: 31549776
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo gene delivery using chitosan/hyaluronic acid nanoparticles: Influences of molecular mass of hyaluronic acid and lyophilization on transfection efficiency.
Sato T; Nakata M; Yang Z; Torizuka Y; Kishimoto S; Ishihara M
J Gene Med; 2017 Aug; 19(8):. PubMed ID: 28667693
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of inflammation and cartilage degradation by sulfasalazine-containing hyaluronic acid on osteoarthritis rat model.
Kim SE; Lee JY; Shim KS; Lee S; Min K; Bae JH; Kim HJ; Park K; Song HR
Int J Biol Macromol; 2018 Jul; 114():341-348. PubMed ID: 29548914
[TBL] [Abstract][Full Text] [Related]
19. The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis.
Sundman EA; Cole BJ; Karas V; Della Valle C; Tetreault MW; Mohammed HO; Fortier LA
Am J Sports Med; 2014 Jan; 42(1):35-41. PubMed ID: 24192391
[TBL] [Abstract][Full Text] [Related]
20. Effect of diclofenac etalhyaluronate (SI-613) on the production of high molecular weight sodium hyaluronate in human synoviocytes.
Kisukeda T; Onaya J; Yoshioka K
BMC Musculoskelet Disord; 2019 May; 20(1):201. PubMed ID: 31077160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
